Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents

Specific modifications of colchicine followed by synthesis of its analogues have been tested in vitro with the objective of lowering colchicine toxicity. Our previous studies have clearly shown the anticancer potential of double-modified colchicine derivatives in C-7 and C-10 positions. Here, a seri...

Full description

Bibliographic Details
Main Authors: Urszula Majcher, Greta Klejborowska, Magdalena Kaik, Ewa Maj, Joanna Wietrzyk, Mahshad Moshari, Jordane Preto, Jack A. Tuszynski, Adam Huczyński
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/7/11/216
_version_ 1797762753795981312
author Urszula Majcher
Greta Klejborowska
Magdalena Kaik
Ewa Maj
Joanna Wietrzyk
Mahshad Moshari
Jordane Preto
Jack A. Tuszynski
Adam Huczyński
author_facet Urszula Majcher
Greta Klejborowska
Magdalena Kaik
Ewa Maj
Joanna Wietrzyk
Mahshad Moshari
Jordane Preto
Jack A. Tuszynski
Adam Huczyński
author_sort Urszula Majcher
collection DOAJ
description Specific modifications of colchicine followed by synthesis of its analogues have been tested in vitro with the objective of lowering colchicine toxicity. Our previous studies have clearly shown the anticancer potential of double-modified colchicine derivatives in C-7 and C-10 positions. Here, a series of novel triple-modified colchicine derivatives is reported. They have been obtained following a four-step strategy. In vitro cytotoxicity of these compounds has been evaluated against four human tumor cell lines (A549, MCF-7, LoVo, and LoVo/DX). Additionally, the mode of binding of the synthesized compounds was evaluated in silico using molecular docking to a 3D structure of β-tubulin based on crystallographic data from the Protein Data Bank and homology methodology. Binding free energy estimates, binding poses, and MlogP values of the compounds were obtained. All triple-modified colchicine derivatives were shown to be active at nanomolar concentrations against three of the investigated cancer cell lines (A549, MCF-7, LoVo). Four of them also showed higher potency against tumor cells over normal cells as confirmed by their high selectivity index values. A vast majority of the synthesized derivatives exhibited several times higher cytotoxicity than colchicine, doxorubicin, and cisplatin.
first_indexed 2024-03-12T19:31:57Z
format Article
id doaj.art-d90acafa95da486eb8b4778010df8387
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T19:31:57Z
publishDate 2018-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-d90acafa95da486eb8b4778010df83872023-08-02T04:28:43ZengMDPI AGCells2073-44092018-11-0171121610.3390/cells7110216cells7110216Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer AgentsUrszula Majcher0Greta Klejborowska1Magdalena Kaik2Ewa Maj3Joanna Wietrzyk4Mahshad Moshari5Jordane Preto6Jack A. Tuszynski7Adam Huczyński8Department of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznan, PolandDepartment of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznan, PolandDepartment of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznan, PolandHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, PolandHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, PolandDepertment of Chemistry, University of Alberta, Edmonton, AB T6G 1Z2, CanadaDepertment of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, CanadaDepertment of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, CanadaDepartment of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznan, PolandSpecific modifications of colchicine followed by synthesis of its analogues have been tested in vitro with the objective of lowering colchicine toxicity. Our previous studies have clearly shown the anticancer potential of double-modified colchicine derivatives in C-7 and C-10 positions. Here, a series of novel triple-modified colchicine derivatives is reported. They have been obtained following a four-step strategy. In vitro cytotoxicity of these compounds has been evaluated against four human tumor cell lines (A549, MCF-7, LoVo, and LoVo/DX). Additionally, the mode of binding of the synthesized compounds was evaluated in silico using molecular docking to a 3D structure of β-tubulin based on crystallographic data from the Protein Data Bank and homology methodology. Binding free energy estimates, binding poses, and MlogP values of the compounds were obtained. All triple-modified colchicine derivatives were shown to be active at nanomolar concentrations against three of the investigated cancer cell lines (A549, MCF-7, LoVo). Four of them also showed higher potency against tumor cells over normal cells as confirmed by their high selectivity index values. A vast majority of the synthesized derivatives exhibited several times higher cytotoxicity than colchicine, doxorubicin, and cisplatin.https://www.mdpi.com/2073-4409/7/11/216colchicine binding site inhibitortubulin-targeting agentantimitotic agentantiproliferative activitythiocolchicinenatural compounds
spellingShingle Urszula Majcher
Greta Klejborowska
Magdalena Kaik
Ewa Maj
Joanna Wietrzyk
Mahshad Moshari
Jordane Preto
Jack A. Tuszynski
Adam Huczyński
Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
Cells
colchicine binding site inhibitor
tubulin-targeting agent
antimitotic agent
antiproliferative activity
thiocolchicine
natural compounds
title Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
title_full Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
title_fullStr Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
title_full_unstemmed Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
title_short Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
title_sort synthesis and biological evaluation of novel triple modified colchicine derivatives as potent tubulin targeting anticancer agents
topic colchicine binding site inhibitor
tubulin-targeting agent
antimitotic agent
antiproliferative activity
thiocolchicine
natural compounds
url https://www.mdpi.com/2073-4409/7/11/216
work_keys_str_mv AT urszulamajcher synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT gretaklejborowska synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT magdalenakaik synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT ewamaj synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT joannawietrzyk synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT mahshadmoshari synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT jordanepreto synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT jackatuszynski synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents
AT adamhuczynski synthesisandbiologicalevaluationofnoveltriplemodifiedcolchicinederivativesaspotenttubulintargetinganticanceragents